Impax Suit Against Pfizer Denied In IP Fight Over Detrol

Law360, New York (October 4, 2011, 9:13 PM EDT) -- A New Jersey federal judge on Friday tossed a suit lodged against Pfizer Inc., ending Impax Laboratories Inc.’s bid for judgment that a generic version of bladder control drug Detrol did not infringe the pharmaceutical giant’s patent.

U.S. District Dennis M. Cavanaugh granted a motion to dismiss filed by Pfizer and its affiliates Pharmacia & Upjohn Co. LLC and Pfizer Health AB, saying Impax has no standing to bring the suit because it suffered no injury. 

Impax is barred from marketing its generic Detrol until September...
To view the full article, register now.